Randomized Controlled Trial of Oxybutynin Extended Release Versus Placebo for Urinary Symptoms During Intravesical Bacillus Calmette-Guérin Treatment

PURPOSE: Intravesical bacillus Calmette-Guérin is used to decrease recurrence rates of nonmuscle invasive urothelial carcinoma. Irritative urinary symptoms are a common side effect of treatment and frequently limit treatment tolerance. While anticholinergic medications may be used for symptom prophy...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Johnson, Michael H., Nepple, Kenneth G., Peck, Vicky, Trinkaus, Kathryn, Klim, Aleksandra, Sandhu, Gurdarshan S., Kibel, Adam S.
Format: Artigo
Langue:Inglês
Publié: 2012
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4150693/
https://ncbi.nlm.nih.gov/pubmed/23123375
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2012.10.070
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires